Skip to main content
OpenTrials
Recruiting

NCT Number: NCT01840930

Cohort of Children With Severe Cerebral Palsy

" Cohort CP " is a multicentre cohort study, initiated by the Hospices Civils de Lyon in September 2009. Population targeted are children with bilateral cerebral palsy, level GMFCS IV or V, aged from 2 to 10 years at inclusion. They are followed-up during 10 years, at the rhythm of 1 visit per year. At each visit are collected clinical, orthopaedic, radiological and environmental data.

The primary objective is to establish the incidence of orthopaedic complications (scoliosis and hip joint) depending on patients' age.

Secondary objectives are to describe the sequences over time of these complications and the related pain, to explore the impact of nutrition, surgery, asymmetric postures and environmental factors, and to describe the medical and rehabilitative follow-up of these patients.

385 patients are expected by the end of 2020. We expect of this long-term follow-up to gain tools that permit to improve patient's care and patient's quality of life, by putting in place preventing actions and adapted treatments related to their own pathologies.

Recruiting

Interested in participating?

Request Info

Key information

Age range

2 year–10 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Children aged from 2 to 10 years at inclusion,
  • with bilateral cerebral palsy,
  • Grade IV or V of the GMFCS.
  • Affiliated with the French healthcare system.
  • Oral consent of the parents obtained.

Exclusion criteria

  • Progressive pathology.

Treatment and study plan

Primary outcomes

  1. Change of hip migration (%) and/or scoliosis (Cobb angle) during the 10 years of patients' follow-up.

    Time frame: Day 0, year 1, year 2, year 3, year 4, year 5, year 6, year 7, year 8, year 9, year 10

    Hip migration is measured in percentage (Rimers method), and scoliosis is measured in degrees (Cobb angle).

    For the first visit (A00= inclusion), if hip migration measured on the last radiography is ≥ 20%, it is asked to trace the history of the migration with measurements of previous patient's radiographies. For this first visit, if the Cobb angle on the last radiography is ≥ 20°, it is also asked to trace history of scoliosis with previous radiographies.

    For the following visits (A01 to A10), only the last radiography is required for each year.

Secondary outcomes

  1. Impact of nutrition on the occurrence of orthopedic complications and related pain.

    Time frame: Day 0, year 1, year 2, year 3, year 4, year 5, year 6, year 7, year 8, year 9, year 10

    Occurrence of hip migration or scoliosis correlated with annual measurement of nutritional state. Nutritional state is measured by weight, size, skinfold, and description of alimentation mode.

  2. Impact of surgical treatment of hip luxation on pain.

    Time frame: Day 0, year 1, year 2, year 3, year 4, year 5, year 6, year 7, year 8, year 9, year 10

    Subjects split into 2 groups: pain / without pain; comparison of percentages of children operated into each group.

  3. Impact of asymmetric postures on the occurrence of orthopedic complications and related pain.

    Time frame: Day 0, year 1, year 2, year 3, year 4, year 5, year 6, year 7, year 8, year 9, year 10

    Frequency of windswept attitude function of type of bearings and postures.

  4. Relationship between neurological asymmetry and windswept and/or hip joint.

    Time frame: Day 0, year 1, year 2, year 3, year 4, year 5, year 6, year 7, year 8, year 9, year 10

    Frequency of neurological asymmetry function of windswept laterality and/or hip joint.

  5. Relationship between environmental factors and orthopedic complications, pain, and nutrition.

    Time frame: Day 0, year 1, year 2, year 3, year 4, year 5, year 6, year 7, year 8, year 9, year 10

    Correlation between patient's environment, hip migration and scoliosis, pain and nutrition.

  6. Description of the rehabilitative and medical follow-up in the studied population.

    Time frame: Day 0, year 1, year 2, year 3, year 4, year 5, year 6, year 7, year 8, year 9, year 10

    Recording of the main steps of medical and rehabilitative care received by each patient.

  7. Description of the sequences over time of orthopedic complications and the related pain.

    Time frame: Day 0, year 1, year 2, year 3, year 4, year 5, year 6, year 7, year 8, year 9, year 10

    Pattern of individual evolution of pain function of age, and quantification of orthopedic surgery impact on pain evolution.

    Pain is measured with the DESS scale (Douleur Enfant San Salvadour) for children with no oral language, or with the VAS (Visual Analogue Scale) for children who have an oral language. In addition, the location, the frequency and the length of time of the related pain are recorded on the Case Report Form.

Study contacts

Contact information is provided by the study sponsor or research team.

Isabelle POIROT, PhD

CONTACT

[email protected]

4 78 86 16 64 ext. +33

Valérie LAUDY

CONTACT

[email protected]

4 72 35 75 51 ext. +33

Sponsors and collaborators

Lead sponsor

Hospices Civils de Lyon

Other

Registry information

Official study title

Longitudinal Study of a Children Population With Bilateral Severe Cerebral Palsy: Incidence and Evolution of Orthopaedic Complications and Pain Related With These Complications.

Acronym: CPCohort

Important dates

Study start
2009
Primary completion
2030
Study completion
2030
First posted
Apr 26, 2013
Registry last updated
Jan 18, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.